Pharmacy provisions in health care reform bill will help pharmacists improve patient outcomes: NCPA

NewsGuard 100/100 Score

Pharmacy provisions included in health care reform legislation passed by the U.S. House of Representatives will improve community pharmacists' ability to improve patient outcomes and reduce costs, the National Community Pharmacists Association (NCPA) said today.

The most noteworthy provisions scale back drastic cuts in reimbursement for Medicaid generic prescription drugs; require limited disclosure from pharmacy benefit managers (PBMs) operating in the new "exchanges" to hold down costs; and exempt most pharmacies from the Medicare Part B Durable Medical Equipment, Prosthetics and Supplies (DMEPOS) accreditation requirement.

In response, Bruce T. Roberts, RPh, NCPA executive vice president and CEO, issued the following statement:

"The pharmacy provisions in the health care bill passed by the House of Representatives are welcome steps towards improving the delivery of prescription drug services to patients across America. Once the bill becomes law, many community pharmacies can continue serving Medicaid patients as well as offering Medicare beneficiaries' essential medical supplies, like diabetes testing strips.

"In addition, federal officials, patients and taxpayers would benefit from having greater access to information about practices that may only pad PBM profits while raising health care costs. The lack of transparency largely leaves health plan sponsors and patients in the dark. Increasingly, public and private payers are reducing drug costs through greater transparency.

"Throughout this entire health care reform process, community pharmacists have offered constructive solutions. The effective and efficient delivery of prescription drug services can produce considerable benefits, as demonstrated by examples like the Asheville Project. Community pharmacists' effort to be a positive force for change will not end when this bill becomes law. Other challenges remain and the implementation process will require our input to ensure the transition is a smooth one."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Effects of varying COVID-19 vaccination rates on population-level health outcomes across variant waves in the U.S.